Catalog name Description price
R-M-942 MeOSuc-Ala-Ala-Pro-Met-AMC,CAS :201853-55-6 MeOSuc-AAPM-AMC, a fluorogenic substrate for cathepsin G. price>
R-M-943 MeOSuc-Ala-Ala-Pro-Val-AMC ,CAS:72252-90-5 A highly sensitive fluorogenic substrate for the assay of human neutrophil and porcine pancreatic elastases. MeOSuc-AAPV-AMC is also cleaved by myeloblastin. price>
R-M-958 Methoxycarbonyl-D-Nle-Gly-Arg-pNA acetate salt,CAS :104186-68-7 Substrate for coagulation factor Xa and, in the presence of 33% ethylenene glycol, IXa (Km = 3.62 mM, pH 7.4). price>
R-M-985 Myosin Light Chain Kinase (480-501),CAS :313642-00-1 This peptide inhibited calmodulin-dependent activation of the smooth muscle myosin light chain kinase with an IC₅₀ of 46 nM. At saturating concentrations of calmodulin, it inhibited myosin light chain and synthetic peptide substrate phosphorylation competitively with IC₅₀ values of 2.7 and 0.9 µM, respectively. price>
R-M-1009 Neuronostatin-13 (mouse, rat) trifluoroacetate salt,CAS :1872435-05-6 Neuronostatin-13 (mouse, rat) trifluoroacetate salt,CAS :1872435-05-6 from ruixi.It is a synthetic peptide, Ruixi can provide a variety of custom peptides. price>
R-M-1033 (Trp¹¹)-Neurotensin,CAS:75644-95-0 This neurotensin analog, in which Tyr¹¹ is substituted by Trp, was found to be as potent as neurotensin in both binding and biological assays in the rat. In contrast, this analog was about 10 times less potent than neurotensin in the guinea-pig. price>
R-M-1044 Orexin A (16-33) trifluoroacetate salt,CAS:1374694-00-4 OXA 16-33 lacks the disulfide bridges of orexin A, but retains a part of the activity of full-length OXA/OXB. The peptide has been used in place of the intact neuropeptide. price>
R-M-1150 SAMS Peptide trifluoroacetate salt,CAS:125911-68-4 Specific substrate for the sucrose-non-fermenting protein kinase (SNF1) from Saccharomyces cerevisiae and its mammalian counterpart, AMP-activated protein kinase (AMPK). price>
R-M-1190 (D-Arg¹,D-Phe⁵,D-Trp⁷·⁹,Leu¹¹)-Substance P,CAS : 96736-12-8 (D-Arg¹,D-Phe⁵,D-Trp⁷·⁹,Leu¹¹)-Substance P initially described as a low potency ghrelin receptor antagonist has surprisingly been found to be a full inverse agonist (EC₅₀ = 5.2 nM). price>
R-M-1191 (Sar⁹,Met(O₂)¹¹)-Substance P,CAS:110880-55-2 This NK-1 receptor agonist exhibits the highest selectivity for NK-1 receptors in various bioassays. It evokes a concentration-dependent increase in mucus secretion and is much more potent than substance P (EC₅₀= 1.7 · 10-⁶M). price>